Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 3
This trial is looking at a new drug called AZD9833 for breast cancer that has come back or spread to another part of the body.
It is for people whose cancer has:
a lot of hormone receptors ()
and only a small number of receptors for (HER2 negative)
Recruitment start: 5 June 2021
Recruitment end: 30 November 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Richard Baird
AstraZeneca
Last reviewed: 13 Dec 2023
CRUK internal database number: 17561
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
